Heart4Data: Consortium agreement SELEQT-HF

A big milestone for Heart4Data: On June 1, 2023, the consortium agreement for the SELEQT-HF research project was signed! This project is a collaboration between ZonMw, Netherlands Heart Institute, NHR, Dutch CardioVascular Alliance, WCN, Harteraad, NVVC, Health-RI, NVT, Pharma Nord, Zuyderland, Erasmus MC, UMCG & Amsterdam UMC.

Principal investigators Jeroen Schaap and Peter van der Meer lead this RB-RCT (registry based, randomized clinical trail) which studies the effect of Selenium/CoQ10 supplements in patients with chronic heart failure (HF). The registry-based study with double-blind randomization ensures that a diverse group of patients can be included, without pre-selection.

SELEQT-HF is part of the DCVA consortium Heart4Data, which aims to create a sustainable infrastructure for registration-based research into HF. As the first clinical trial within this infrastructure, SELEQT-HF will test and help develop its functionality, including the steps towards EHR-based registration to reduce registration burden.

Upcoming milestones: Participation of the first 10 hospitals for EHR based registration, approval of the Medical Ethics Review Committee (METC) and the inclusion of the first patient.

To stay informed? Check out the website and follow the Heart4Data LinkedIn page.